Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Youri Hoogstrate"'
Autor:
Job van Riet, Chinmoy Saha, Nikolaos Strepis, Rutger W. W. Brouwer, Elena S. Martens-Uzunova, Wesley S. van de Geer, Sigrid M. A. Swagemakers, Andrew Stubbs, Yassir Halimi, Sanne Voogd, Arif Mohammad Tanmoy, Malgorzata A. Komor, Youri Hoogstrate, Bart Janssen, Remond J. A. Fijneman, Yashar S. Niknafs, Arul M. Chinnaiyan, Wilfred F. J. van IJcken, Peter J. van der Spek, Guido Jenster, Rogier Louwen
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-13 (2022)
CRISPR elements in the human genome are expressed in both healthy tissues and tumors but with distinct patterns, representing a potential biomarker for cancer.
Externí odkaz:
https://doaj.org/article/f067cb604205407abac008b0006c1b2e
Publikováno v:
BMC Bioinformatics, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background The FASTA file format, used to store polymeric sequence data, has become a bioinformatics file standard used for decades. The relatively large files require additional files, beyond the scope of the original format, to identify se
Externí odkaz:
https://doaj.org/article/fbb2aed2325b447aa3f461d033a7c2f8
Autor:
Chao Zhang, Jochem Bijlard, Christine Staiger, Serena Scollen, David van Enckevort, Youri Hoogstrate, Alexander Senf, Saskia Hiltemann, Susanna Repo, Wibo Pipping, Mariska Bierkens, Stefan Payralbe, Bas Stringer, Jaap Heringa, Andrew Stubbs, Luiz Olavo Bonino Da Silva Santos, Jeroen Belien, Ward Weistra, Rita Azevedo, Kees van Bochove, Gerrit Meijer, Jan-Willem Boiten, Jordi Rambla, Remond Fijneman, J. Dylan Spalding, Sanne Abeln
Publikováno v:
F1000Research, Vol 6 (2017)
The availability of high-throughput molecular profiling techniques has provided more accurate and informative data for regular clinical studies. Nevertheless, complex computational workflows are required to interpret these data. Over the past years,
Externí odkaz:
https://doaj.org/article/8068df77a81040238f5683ddfcc9daad
Autor:
Youri Hoogstrate, Chao Zhang, Alexander Senf, Jochem Bijlard, Saskia Hiltemann, David van Enckevort, Susanna Repo, Jaap Heringa, Guido Jenster, Remond J.A. Fijneman, Jan-Willem Boiten, Gerrit A. Meijer, Andrew Stubbs, Jordi Rambla, Dylan Spalding, Sanne Abeln
Publikováno v:
F1000Research, Vol 5 (2016)
High-throughput molecular profiling techniques are routinely generating vast amounts of data for translational medicine studies. Secure access controlled systems are needed to manage, store, transfer and distribute these data due to its personally id
Externí odkaz:
https://doaj.org/article/2f45112fd2b54b64862983518402ef2d
Autor:
Martin J. van den Bent, Pim J. French, Thierry Gorlia, Brigitta G. Baumert, Vassilis Golfinopoulos, Kin Jip Cheung, Wilfred F.J. van IJcken, Rutger W.W. Brouwer, Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Iris de Heer, Youri Hoogstrate, Andreas von Deimling, Pieter Wesseling, Johan M. Kros, Robert B. Jenkins, Kenneth Aldape, Myra E. van Linde, Catherine McBain, Michael Weller, Roberta Rudà, Walter Taal, Leland Rogers, Matthew Griffin, Sanjeev Gill, Olivier L. Chinot, Helen Wheeler, Warren P. Mason, Jean-Francois Baurain, Anna K. Nowak, Michael A. Vogelbaum, Sara C. Erridge, Paul M. Clement, Alba A. Brandes, Wolfgang Wick, Marc Sanson, C. Mircea S. Tesileanu
Supplementary Data from Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109744a2c92862781132af0ecf222543
https://doi.org/10.1158/1078-0432.22487442
https://doi.org/10.1158/1078-0432.22487442
Autor:
Martin J. van den Bent, Pim J. French, Thierry Gorlia, Brigitta G. Baumert, Vassilis Golfinopoulos, Kin Jip Cheung, Wilfred F.J. van IJcken, Rutger W.W. Brouwer, Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Iris de Heer, Youri Hoogstrate, Andreas von Deimling, Pieter Wesseling, Johan M. Kros, Robert B. Jenkins, Kenneth Aldape, Myra E. van Linde, Catherine McBain, Michael Weller, Roberta Rudà, Walter Taal, Leland Rogers, Matthew Griffin, Sanjeev Gill, Olivier L. Chinot, Helen Wheeler, Warren P. Mason, Jean-Francois Baurain, Anna K. Nowak, Michael A. Vogelbaum, Sara C. Erridge, Paul M. Clement, Alba A. Brandes, Wolfgang Wick, Marc Sanson, C. Mircea S. Tesileanu
Purpose:In a post hoc analysis of the CATNON trial (NCT00626990), we explored whether adding temozolomide to radiotherapy improves outcome in patients with IDH1/2 wildtype (wt) anaplastic astrocytomas with molecular features of glioblastoma [redesign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88b32e4e9c69dd0eaf37cef44fe94660
https://doi.org/10.1158/1078-0432.c.6532518
https://doi.org/10.1158/1078-0432.c.6532518
Autor:
Martin J. van den Bent, Pim J. French, Thierry Gorlia, Brigitta G. Baumert, Vassilis Golfinopoulos, Kin Jip Cheung, Wilfred F.J. van IJcken, Rutger W.W. Brouwer, Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Iris de Heer, Youri Hoogstrate, Andreas von Deimling, Pieter Wesseling, Johan M. Kros, Robert B. Jenkins, Kenneth Aldape, Myra E. van Linde, Catherine McBain, Michael Weller, Roberta Rudà, Walter Taal, Leland Rogers, Matthew Griffin, Sanjeev Gill, Olivier L. Chinot, Helen Wheeler, Warren P. Mason, Jean-Francois Baurain, Anna K. Nowak, Michael A. Vogelbaum, Sara C. Erridge, Paul M. Clement, Alba A. Brandes, Wolfgang Wick, Marc Sanson, C. Mircea S. Tesileanu
Supplementary Figure from Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21d66230eb0256698fea2e10f6ea94c9
https://doi.org/10.1158/1078-0432.22487427.v1
https://doi.org/10.1158/1078-0432.22487427.v1
Autor:
Pim J. French, Johan M. Kros, Peter A.E. Sillevis Smitt, René M. Vernhout, Bronno van der Holt, Aafke H. Honkoop, Jan Buter, Monique C.J. Hanse, Laurens V. Beerepoot, Annemiek Walenkamp, Hendrika M. Oosterkamp, Walter Taal, Maurice de Wit, Ya Gao, René Böttcher, Peter van der Spek, Andrew Stubbs, Hina Naz-Khan, Youri Hoogstrate, Martin J. van den Bent, Lale Erdem-Eraslan
Mutations segregate in distinct molecular subtypes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a36b6f197483cbc756075c5f698cbd8
https://doi.org/10.1158/0008-5472.22408541.v1
https://doi.org/10.1158/0008-5472.22408541.v1
Autor:
Pim J. French, Johan M. Kros, Peter A.E. Sillevis Smitt, René M. Vernhout, Bronno van der Holt, Aafke H. Honkoop, Jan Buter, Monique C.J. Hanse, Laurens V. Beerepoot, Annemiek Walenkamp, Hendrika M. Oosterkamp, Walter Taal, Maurice de Wit, Ya Gao, René Böttcher, Peter van der Spek, Andrew Stubbs, Hina Naz-Khan, Youri Hoogstrate, Martin J. van den Bent, Lale Erdem-Eraslan
Reclassification of Phillips dataset primary v recurrent samples.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90d9ad032405a97ca3b399d1ac4c9e80
https://doi.org/10.1158/0008-5472.22408505.v1
https://doi.org/10.1158/0008-5472.22408505.v1
Autor:
Pim J. French, Johan M. Kros, Peter A.E. Sillevis Smitt, René M. Vernhout, Bronno van der Holt, Aafke H. Honkoop, Jan Buter, Monique C.J. Hanse, Laurens V. Beerepoot, Annemiek Walenkamp, Hendrika M. Oosterkamp, Walter Taal, Maurice de Wit, Ya Gao, René Böttcher, Peter van der Spek, Andrew Stubbs, Hina Naz-Khan, Youri Hoogstrate, Martin J. van den Bent, Lale Erdem-Eraslan
The results from the randomized phase II BELOB trial provided evidence for a potential benefit of bevacizumab (beva), a humanized monoclonal antibody against circulating VEGF-A, when added to CCNU chemotherapy in patients with recurrent glioblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a25cac1b80eba75c11040b651d6e1271
https://doi.org/10.1158/0008-5472.c.6507551.v1
https://doi.org/10.1158/0008-5472.c.6507551.v1